塔塔盒结合蛋白促进肝细胞癌的转移,通过表皮细胞-介质细胞过渡
Jiayi Cao1, Suzhen Yang2,3, Tingting Luo1
1Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, School of Medicine, Northwest University, Shaanxi, Xi'an, China.
Hepatology communications
|June 14, 2023
概括
塔塔盒结合蛋白 (TBP) 通过增加PXN表达来促进肝细胞癌 (HCC) 转移,驱动上皮细胞-介质细胞过渡. 这一发现揭示了TBP作为HCC进展的关键机制和潜在的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 基因规则 基因规则
背景情况:
- 肝细胞癌 (HCC) 的特点是转移和复发率高.
- 了解驱动HCC转移的分子机制对于改善患者的治疗结果至关重要.
- 一般转录因子TATA盒结合蛋白 (TBP) 在调节基因转录方面发挥作用.
研究的目的:
- 研究TATA盒结合蛋白 (TBP) 在肝细胞癌 (HCC) 转移中的作用.
- 阐明TBP影响HCC进展的分子机制.
主要方法:
- 使用PCR,西部斑块和免疫组织化学量化TBP表达.
- RNA测序确定了TBP的下游目标.
- 在HCC细胞系和异种移植模型中进行了体外和体外功能测定.
- 露西法酶记者和染色体免疫沉测定阐明了调节机制.
主要成果:
- 在HCC患者中,高TBP表达与预后不佳相关.
- 提升TBP的调控增强了HCC转移在体外和体内.
- TBP直接对MBNL3表达进行了交换,从而促进了lncRNA-PXN-AS1.1的外显子纳入.
- 这一过程导致了上皮细胞-介质细胞过渡和通过PXN上调调节的HCC进展.
结论:
- TBP上调是增强HCC转移的一个重要机制.
- 通过MBNL3和替代拼接,TBP通过增加PXN表达来驱动HCC的进展.
- 向TBP可能提供一种抑制HCC转移的治疗策略.
相关概念视频
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
Cadherins in Tissue Organization
3.0K
The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
Cell Sorting During Development
Cell sorting plays an...
3.0K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
MAPK Signaling Cascades
5.7K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.7K
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K


